FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897731470> ?p ?o ?g. }

• W2897731470 endingPage "1206.e3" @default.
• W2897731470 startingPage "1197" @default.
• W2897731470 abstract "Background There have been concerns about the risk of inhaled corticosteroid (ICS)-related tuberculosis (TB) development. Objective We investigated the occurrence of TB among ICS users according to underlying respiratory diseases and type of ICS. Methods A 12-year population cohort comprising approximately 1 million subjects collected from the Korean claims database were used. Adult ICS users (budesonide or fluticasone) were enrolled. The temporal relationship between TB development and the last ICS prescription before TB development was evaluated. A nested case-control study was performed with 1:4 matching for age, sex, and the initiation date of the ICS. Results There were 17,991 ICS users, and 175 developed TB during the study period. Approximately 80% (140/175) of patients who developed TB were diagnosed within 3 years after the last ICS prescription. In the nested case-control study, the occurrence of TB was not related to the type of ICS, but was related to a higher annual admission rate and a higher comorbidity score. The risk of TB was higher in patients with chronic obstructive pulmonary disease (COPD) than in those with asthma (odds ratio: 2.31; CI 95%: 1.39-3.38; P = .0011) after adjusting for covariates. The subgroup analysis revealed no difference between budesonide and fluticasone with respect to the risk of developing TB in patients with asthma, COPD, or asthma-COPD overlap syndrome. Conclusion An increased risk of TB development may persist for 3 years after stopping the ICS and the risk is higher in patients with COPD regardless of the type of ICS used. There have been concerns about the risk of inhaled corticosteroid (ICS)-related tuberculosis (TB) development. We investigated the occurrence of TB among ICS users according to underlying respiratory diseases and type of ICS. A 12-year population cohort comprising approximately 1 million subjects collected from the Korean claims database were used. Adult ICS users (budesonide or fluticasone) were enrolled. The temporal relationship between TB development and the last ICS prescription before TB development was evaluated. A nested case-control study was performed with 1:4 matching for age, sex, and the initiation date of the ICS. There were 17,991 ICS users, and 175 developed TB during the study period. Approximately 80% (140/175) of patients who developed TB were diagnosed within 3 years after the last ICS prescription. In the nested case-control study, the occurrence of TB was not related to the type of ICS, but was related to a higher annual admission rate and a higher comorbidity score. The risk of TB was higher in patients with chronic obstructive pulmonary disease (COPD) than in those with asthma (odds ratio: 2.31; CI 95%: 1.39-3.38; P = .0011) after adjusting for covariates. The subgroup analysis revealed no difference between budesonide and fluticasone with respect to the risk of developing TB in patients with asthma, COPD, or asthma-COPD overlap syndrome. An increased risk of TB development may persist for 3 years after stopping the ICS and the risk is higher in patients with COPD regardless of the type of ICS used." @default.
• W2897731470 created "2018-10-26" @default.
• W2897731470 creator A5003035653 @default.
• W2897731470 creator A5003062205 @default.
• W2897731470 creator A5024260821 @default.
• W2897731470 creator A5040942248 @default.
• W2897731470 creator A5057257626 @default.
• W2897731470 creator A5065072134 @default.
• W2897731470 creator A5067962158 @default.
• W2897731470 creator A5088682153 @default.
• W2897731470 date "2019-04-01" @default.
• W2897731470 modified "2023-10-16" @default.
• W2897731470 title "Inhaled Corticosteroid-Related Tuberculosis in the Real World Among Patients with Asthma and COPD: A 10-Year Nationwide Population-Based Study" @default.
• W2897731470 cites W1984045504 @default.
• W2897731470 cites W2005838858 @default.
• W2897731470 cites W2053127947 @default.
• W2897731470 cites W2065764124 @default.
• W2897731470 cites W2066191620 @default.
• W2897731470 cites W2068139387 @default.
• W2897731470 cites W2072536470 @default.
• W2897731470 cites W2085303031 @default.
• W2897731470 cites W2094347907 @default.
• W2897731470 cites W2100738224 @default.
• W2897731470 cites W2105577900 @default.
• W2897731470 cites W2107272163 @default.
• W2897731470 cites W2111844812 @default.
• W2897731470 cites W2115438934 @default.
• W2897731470 cites W2129168261 @default.
• W2897731470 cites W2144106599 @default.
• W2897731470 cites W2153284508 @default.
• W2897731470 cites W2169240589 @default.
• W2897731470 cites W2171331726 @default.
• W2897731470 cites W2240386735 @default.
• W2897731470 cites W2755605199 @default.
• W2897731470 cites W2765387099 @default.
• W2897731470 doi "https://doi.org/10.1016/j.jaip.2018.10.007" @default.
• W2897731470 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30339858" @default.
• W2897731470 hasPublicationYear "2019" @default.
• W2897731470 type Work @default.
• W2897731470 sameAs 2897731470 @default.
• W2897731470 citedByCount "9" @default.
• W2897731470 countsByYear W28977314702019 @default.
• W2897731470 countsByYear W28977314702020 @default.
• W2897731470 countsByYear W28977314702021 @default.
• W2897731470 countsByYear W28977314702022 @default.
• W2897731470 countsByYear W28977314702023 @default.
• W2897731470 crossrefType "journal-article" @default.
• W2897731470 hasAuthorship W2897731470A5003035653 @default.
• W2897731470 hasAuthorship W2897731470A5003062205 @default.
• W2897731470 hasAuthorship W2897731470A5024260821 @default.
• W2897731470 hasAuthorship W2897731470A5040942248 @default.
• W2897731470 hasAuthorship W2897731470A5057257626 @default.
• W2897731470 hasAuthorship W2897731470A5065072134 @default.
• W2897731470 hasAuthorship W2897731470A5067962158 @default.
• W2897731470 hasAuthorship W2897731470A5088682153 @default.
• W2897731470 hasConcept C126322002 @default.
• W2897731470 hasConcept C142724271 @default.
• W2897731470 hasConcept C156957248 @default.
• W2897731470 hasConcept C165617652 @default.
• W2897731470 hasConcept C187212893 @default.
• W2897731470 hasConcept C2776042228 @default.
• W2897731470 hasConcept C2776136866 @default.
• W2897731470 hasConcept C2776780178 @default.
• W2897731470 hasConcept C2776804153 @default.
• W2897731470 hasConcept C2779159551 @default.
• W2897731470 hasConcept C2781069245 @default.
• W2897731470 hasConcept C2908647359 @default.
• W2897731470 hasConcept C71924100 @default.
• W2897731470 hasConcept C72563966 @default.
• W2897731470 hasConcept C99454951 @default.
• W2897731470 hasConceptScore W2897731470C126322002 @default.
• W2897731470 hasConceptScore W2897731470C142724271 @default.
• W2897731470 hasConceptScore W2897731470C156957248 @default.
• W2897731470 hasConceptScore W2897731470C165617652 @default.
• W2897731470 hasConceptScore W2897731470C187212893 @default.
• W2897731470 hasConceptScore W2897731470C2776042228 @default.
• W2897731470 hasConceptScore W2897731470C2776136866 @default.
• W2897731470 hasConceptScore W2897731470C2776780178 @default.
• W2897731470 hasConceptScore W2897731470C2776804153 @default.
• W2897731470 hasConceptScore W2897731470C2779159551 @default.
• W2897731470 hasConceptScore W2897731470C2781069245 @default.
• W2897731470 hasConceptScore W2897731470C2908647359 @default.
• W2897731470 hasConceptScore W2897731470C71924100 @default.
• W2897731470 hasConceptScore W2897731470C72563966 @default.
• W2897731470 hasConceptScore W2897731470C99454951 @default.
• W2897731470 hasFunder F4320321248 @default.
• W2897731470 hasFunder F4320321408 @default.
• W2897731470 hasFunder F4320322053 @default.
• W2897731470 hasFunder F4320322120 @default.
• W2897731470 hasIssue "4" @default.
• W2897731470 hasLocation W28977314701 @default.
• W2897731470 hasLocation W28977314702 @default.
• W2897731470 hasOpenAccess W2897731470 @default.
• W2897731470 hasPrimaryLocation W28977314701 @default.
• W2897731470 hasRelatedWork W1795103282 @default.
• W2897731470 hasRelatedWork W1968904563 @default.
• W2897731470 hasRelatedWork W2009564877 @default.
• W2897731470 hasRelatedWork W2051437433 @default.

• next